There is provided the use of a nitro-substituted aromatic compound of formula (I), (II), (III), or (IV) and a copolymers comprising repeat units of formula (III) and/or (IV) as an electrode material as well as the use of such compound in the manufacture of an electrode. An electrode composite material and an electrode comprising this compound are also provided. When used in metal-ion batteries, preferably Li-ion batteries, the electrode of the invention has a combination of high operating voltage (e.g. >2.0 V) and high specific capacities (e.g. >300 mAh g−1). To the best of the inventors' knowledge, some of them have the highest specific capacity, along N with high voltage, among organic electrode materials reported to date for application in alkali-ion batteries. (I), (II), (III), (IV).
H01M 4/60 - Selection of substances as active materials, active masses, active liquids of organic compounds
C07C 205/11 - Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
C07C 205/06 - Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
C07C 205/57 - Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
There are provided processes for treating a residual. For example, such processes can comprise treating a mixture comprising the residual, a peracid or source thereof and an ammonium salt in a reactor, with an electric field, by means of at least one anode and at least one cathode that define therebetween an electrokinetic zone for treating the mixture. Such processes allow for inactivation of at least one type of pathogen in the residual so as to obtain a treated residual.
There is provided the use of a nitro-substituted aromatic compound of formula (I), (II), (III), or (IV) and a copolymers comprising repeat units of formula (III) and/or (IV) as an electrode material as well as the use of such compound in the manufacture of an electrode. An electrode composite material and an electrode comprising this compound are also provided. When used in metal-ion batteries, preferably Li-ion batteries, the electrode of the invention has a combination of high operating voltage (e.g. > 2.0 V) and high specific capacities (e.g. > 300 mAh g-1). To the best of the inventors' knowledge, some of them have the highest specific capacity, along with high voltage, among organic electrode materials reported to date for application in alkali-ion batteries. (I), (II), (III), (IV).
C07C 205/06 - Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
C07C 205/12 - Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
C07C 205/57 - Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
C08F 212/14 - Monomers containing only one unsaturated aliphatic radical containing one ring substituted by hetero atoms or groups containing hetero atoms
H01M 4/60 - Selection of substances as active materials, active masses, active liquids of organic compounds
H01M 4/13 - Electrodes for accumulators with non-aqueous electrolyte, e.g. for lithium-accumulatorsProcesses of manufacture thereof
4.
NITRO-SUBSTITUTED AROMATIC COMPOUNDS FOR USE IN ELECTRODES
There is provided the use of a nitro-substituted aromatic compound of formula (I), (II), (III), or (IV) and a copolymers comprising repeat units of formula (III) and/or (IV) as an electrode material as well as the use of such compound in the manufacture of an electrode. An electrode composite material and an electrode comprising this compound are also provided. When used in metal-ion batteries, preferably Li-ion batteries, the electrode of the invention has a combination of high operating voltage (e.g. > 2.0 V) and high specific capacities (e.g. > 300 mAh g1). To the best of the inventors' knowledge, some of them have the highest specific capacity, along with high voltage, among organic electrode materials reported to date for application in alkali-ion batteries.
C07C 205/06 - Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
H01M 4/13 - Electrodes for accumulators with non-aqueous electrolyte, e.g. for lithium-accumulatorsProcesses of manufacture thereof
C07C 205/12 - Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
C07C 205/57 - Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
C08F 212/14 - Monomers containing only one unsaturated aliphatic radical containing one ring substituted by hetero atoms or groups containing hetero atoms
H01M 4/60 - Selection of substances as active materials, active masses, active liquids of organic compounds
5.
CARBON DOTS, METHODS OF MANUFACTURE THEREOF, AND USES THEREOF IN THE PRODUCTION OF BIOFUEL
The present disclosure relates to carbon dots, uses thereof and methods of manufacture thereof. For example, such carbon dots can be used in the production of biofuels such as biodiesel. For example, these carbon dots can be used as catalysts in transesterification reactions. For example, these carbon dots can be glycine-citric acid carbon dots, amine-passivated carbon dots, or combinations thereof.
C07C 67/03 - Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
C07C 229/08 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
C10G 3/00 - Production of liquid hydrocarbon mixtures from oxygen-containing organic materials, e.g. fatty oils, fatty acids
6.
CARBON DOTS, METHODS OF MANUFACTURE THEREOF, AND USES THEREOF IN THE PRODUCTION OF BIOFUEL
The present disclosure relates to carbon dots, uses thereof and methods of manufacture thereof. For example, such carbon dots can be used in the production of biofuels such as biodiesel. For example, these carbon dots can be used as catalysts in transesterification reactions. For example, these carbon dots can be glycine-citric acid carbon dots, amine-passivated carbon dots, or combinations thereof.
C07C 229/08 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
Membranes for membrane distillation (MD) and forward osmosis (FO) are provided with methods of manufacture and use thereof. The MD membrane comprises a microporous mat of electrospun nanofibers made of a nanocomposite comprising reduced graphene oxide dispersed in a hydrophobic polymer with their surface grafted with a silane coupling agent or with hydrophobic nanoparticles. The FO membrane comprises a microporous support layer and a rejection layer formed on one side of the support layer, wherein the support layer is a microporous mat of electrospun nanofibers made of a nanocomposite of hydrophilic nanoparticles dispersed in a hydrophilic polymer, and the rejection layer is made of nanocomposite of hydrophilic nanoparticles dispersed in a crosslinked meta-aramid of formula (I). There is also provided a process for treating a high-salinity and/or high-strength feed, such as fracking wastewater, comprising microfiltration or ultrafiltration, followed by forward osmosis, and then membrane distillation.
A61K 31/4365 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
A61K 31/4355 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
A61K 31/437 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
C07D 491/048 - Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
The present disclosure relates to fused N-arylsulfonamidyl-thienoisoquinoline compounds, derivatives and pharmaceutical compositions thereof, and methods and uses in inhibiting cancer cell growth, along with a supplemental anti-cancer agent. Centrosome targeting and microtubule depolymerisation are attractive in designing the present chemotherapeutic compounds. The various diseases and conditions treated include various types of cell cancers, and in vitro inhibition.
A61K 31/4436 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
An apparatus for simulating a cardiovascular system comprising a fluid circulation system for simulating at least a portion of a cardiac vasculature. The fluid circulation system comprising a tubing array having at least one outlet and at least one inlet, the at least one outlet and the at least one inlet each being arranged to be removeably connectable to a heart model to form a fluid pathway through the heart model, in use. The apparatus also comprises an activation system for inducing a waveform in fluid in the fluid pathway, in use, the activation system comprising an actuator for applying pressure to an outer surface of the heart model, a support for supporting the heart model whilst the actuator is applying pressure to the heart model, and a motor for driving the actuator, the motor being controllable by a processor, the actuator being arranged to releasably compress the heart model, in use.
The present disclosure provides a variant tyrosine hydroxylase that provides for increased production of L-DOPA in a host cell that expresses the tyrosine hydroxylase. The present disclosure provides nucleic acids encoding the variant tyrosine hydroxylase, and host cells genetically modified with the nucleic acids. The present disclosure provides methods of making L-DOPA in a host cell. The present disclosure provides methods of making a benzylisoquinoline alkaloid (BIA), or a BIA precursor. The present disclosure provides methods of detecting L-DOPA level in a cell. The present disclosure provides methods of identifying tyrosine hydroxylase variants that provide for increased L-DOPA production; and methods of identifying gene products that provide for increased tyrosine production.
A method of coating a substrate with particles comprising providing a suspending liquid in a container; agitating the liquid and, while agitating the liquid adding the particles to the liquid, or adding the particles to the liquid and then agitating the liquid; and while continuing agitating the liquid: (i) allowing a film of the particles to form at the surface of the liquid; and (ii) dip-coating the film on the substrate, wherein said agitating creates a dispersed flow pattern in the suspending liquid, said flow pattern carrying the particles at the surface of the liquid
A concave diffraction grating for integrated optics is constructed by replacing the reflective metallic part by either multiple thin elements of metal or multiple elements of dielectric material, each partially reflecting the light, and arranged on elliptical fashion in order to distribute the diffraction/reflection of light and provide aberration-free focusing, by combining diffraction condition and Bragg condition of these curved reflectors.
G02B 6/34 - Optical coupling means utilising prism or grating
G02B 6/12 - Light guidesStructural details of arrangements comprising light guides and other optical elements, e.g. couplings of the optical waveguide type of the integrated circuit kind
G02B 6/28 - Optical coupling means having data bus means, i.e. plural waveguides interconnected and providing an inherently bidirectional system by mixing and splitting signals
G02B 6/293 - Optical coupling means having data bus means, i.e. plural waveguides interconnected and providing an inherently bidirectional system by mixing and splitting signals with wavelength selective means
G02B 6/124 - Geodesic lenses or integrated gratings
There are provided processes for inactivating pathogens in bio-wastes (i.e., residuals). For example, such processes can comprise treating a mixture comprising the residual (e.g., biosolids, sludge, sediment, municipal solid waste) a peracid or source thereof, and an ammonium salt in a reactor with an electrical field by means of at least an anode and at least one cathode, that define therebetween an electrokinetic zone for treating the mixture. Such processes allow for inactivation of at least one type of pathogen in the residual so as to obtain a treated residual.
A62D 3/10 - Processes for making harmful chemical substances harmless, or less harmful, by effecting a chemical change in the substances by subjecting to electric or wave energy or particle or ionizing radiation
C02F 1/467 - Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection
C02F 1/48 - Treatment of water, waste water, or sewage with magnetic or electric fields
There are provided processes for inactivating pathogens in bio-wastes (i.e., residuals). For example, such processes can comprise treating a mixture comprising the residual (e.g., biosolids, sludge, sediment, municipal solid waste) a peracid or source thereof, and an ammonium salt in a reactor with an electrical field by means of at least an anode and at least one cathode, that define therebetween an electrokinetic zone for treating the mixture. Such processes allow for inactivation of at least one type of pathogen in the residual so as to obtain a treated residual.
A62D 3/10 - Processes for making harmful chemical substances harmless, or less harmful, by effecting a chemical change in the substances by subjecting to electric or wave energy or particle or ionizing radiation
B09C 1/08 - Reclamation of contaminated soil chemically
C02F 1/48 - Treatment of water, waste water, or sewage with magnetic or electric fields
There are provided processes for treating wastewater. The processes can comprise treating a mixture comprising the wastewater and an activated sludge, in a single reactor, with an electric current having a density of less than about 55 A/m2, by means of at least one anode and at least one cathode that define therebetween an electrical zone for treating the mixture; exposing the mixture to an intermittent ON/OFF electrical exposure mode to the electric current in which an OFF period of time is about 1 to about 10 times longer than an ON period of time; and maintaining an adequate oxidation-reduction potential in the single reactor. Such processes allow for substantial removal of carbon, nitrogen and phosphorus from the wastewater in the single reactor of various forms and for obtaining another mixture comprising a treated wastewater and solids.
There are provided processes for treating wastewater. The processes can comprise treating a mixture comprising the wastewater and an activated sludge, in a single reactor, with an electric current having a density of less than about 55 A/m2, by means of at least one anode and at least one cathode that define therebetween an electrical zone for treating the mixture; exposing the mixture to an intermittent ON/OFF electrical exposure mode to the electric current in which an OFF period of time is about 1 to about 10 times longer than an ON period of time; and maintaining an adequate oxidation-reduction potential in the single reactor. Such processes allow for substantial removal of carbon, nitrogen and phosphorus from the wastewater in the single reactor of various forms and for obtaining another mixture comprising a treated wastewater and solids.
Energy is probably one of the most important issues of the current century. New sources, approaches and systems have been studied in order to find suitable and more reliable power sources and energy harvesting devices. In addition, mobile Micro Electro Mechanical Systems (MEMS) devices require micro power sources as well. So far, there has been vast research and investment on solar sources, fuel cells, etc. The present application is an attempt to develop a suitable fabrication method to realize a Photosynthetic Power Cell (μΡSΟ) to harvest the energy from photosynthesis and produce electrical energy. The proposed μΡSΟ is a micro power generation device made from polymer material for generating power from algal photosynthesis. In particular, the present application presents a fabrication process for realising a μΡSΟ from polymer material.
A concave diffraction grating for integrated optics is constructed by replacing the reflective metallic part by either multiple thin elements of metal or multiple elements of dielectric material, each partially reflecting the light, and arranged on elliptical fashion in order to distribute the diffraction/reflection of light and provide aberration-free focusing, by combining diffraction condition and Bragg condition of these curved reflectors.
G02B 27/00 - Optical systems or apparatus not provided for by any of the groups ,
G02B 1/02 - Optical elements characterised by the material of which they are madeOptical coatings for optical elements made of crystals, e.g. rock-salt, semiconductors
G02B 17/00 - Systems with reflecting surfaces, with or without refracting elements
A device, a method of fabricating the device and a sample analysis system that includes the device are provided. The device includes an optical waveguide having a plurality of nanofeatures integrated thereon to influence at least one of evanescence and coupling of an optical field of the optical waveguide. The sample analysis system includes a fluidic actuation system for introducing sample specimen fluid into a microfluidic channel of the device for evanescence based detection.
G02B 6/12 - Light guidesStructural details of arrangements comprising light guides and other optical elements, e.g. couplings of the optical waveguide type of the integrated circuit kind
B82B 1/00 - Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
21.
A MICROFLUIDIC DEVICE AND METHOD FOR FABRICATING THE MICROFLUIDIC DEVICE
The present application is directed to a technological platform with integrated microfluidic and optical modules for bio-detection. The platform enables in-situ detection by integrating fluidics with optical source and detection capabilities within a fabricated microchip. The platform is a polymer-based microfluidic chip having integrated excitation source and detection elements in a vicinity of a microfluidic reaction chamber configured to contain a micro-volume of a test sample. The principle of detection is based on an excitation source induced fluorescence of the test sample within the microfluidic reaction chamber.
The present invention relates tonovel xylanasesXYL001and XYL002, a polynucleotide sequence encoding for the polypeptide according to the invention, a production process for the enzymes according to the invention and the use of the enzymes according to the invention in various industrial processes.
patents
